Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-10 4:14 pm Purchase |
2025-04-03 | 13G | Protagonist Therapeutics, Inc. PTGX |
Deep Track Capital, LP | 3,250,000 5.290% |
3,250,000 (New Position) |
Filing History |
| 2025-02-10 09:00 am Purchase |
2024-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
FARALLON CAPITAL PARTNERS LP | 5,956,488 9.990% |
191,379 (+3.32%) |
Filing History |
| 2025-02-05 1:23 pm Sale |
2024-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
BLACKROCK INC BLK |
9,884,617 16.600% |
-779,078 (-7.31%) |
Filing History |
| 2024-11-14 4:27 pm Sale |
2024-09-30 | 13G | Protagonist Therapeutics, Inc. PTGX |
BIOTECHNOLOGY VALUE FUND L P | 2,970,427 4.900% |
-2,793,521 (-48.47%) |
Filing History |
| 2024-11-12 4:51 pm Unchanged |
2024-09-30 | 13G | Protagonist Therapeutics, Inc. PTGX |
The Vanguard Group | 4,216,081 7.150% |
0 (Unchanged) |
Filing History |
| 2024-11-04 1:22 pm Purchase |
2024-09-30 | 13G | Protagonist Therapeutics, Inc. PTGX |
The Vanguard Group | 4,216,081 7.150% |
1,062,165 (+33.68%) |
Filing History |
| 2024-10-16 12:48 pm Purchase |
2024-09-30 | 13G | Protagonist Therapeutics, Inc. PTGX |
STATE STREET CORP STT |
3,183,542 5.400% |
453,613 (+16.62%) |
Filing History |
| 2024-08-07 4:10 pm Purchase |
2024-07-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
BLACKROCK INC BLK |
10,663,695 18.200% |
5,119,793 (+92.35%) |
Filing History |
| 2024-02-14 4:58 pm Sale |
2023-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
Citadel Advisors LLC | 390,512 0.700% |
-2,292,302 (-85.44%) |
Filing History |
| 2024-02-14 09:31 am Purchase |
2023-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
BIOTECHNOLOGY VALUE FUND L P | 5,763,948 9.990% |
738,048 (+14.68%) |
Filing History |
| 2024-02-14 07:47 am Purchase |
2023-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
RTW Investments, LP | 5,315,514 9.200% |
1,723,528 (+47.98%) |
Filing History |
| 2024-02-14 07:15 am Sale |
2023-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
Point72 Asset Management, L.P. | 2,613,453 4.500% |
-572,624 (-17.97%) |
Filing History |
| 2024-02-13 5:12 pm Purchase |
2023-12-29 | 13G | Protagonist Therapeutics, Inc. PTGX |
The Vanguard Group | 3,153,916 5.470% |
56,202 (+1.81%) |
Filing History |
| 2024-02-07 07:41 am Sale |
2023-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
ADAGE CAPITAL PARTNERS GP LLC | 1,291,701 2.240% |
-1,663,299 (-56.29%) |
Filing History |
| 2024-02-02 09:19 am Purchase |
2023-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
FARALLON CAPITAL PARTNERS LP | 5,765,109 9.990% |
710,007 (+14.05%) |
Filing History |
| 2024-01-24 2:27 pm Purchase |
2023-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
BLACKROCK INC BLK |
5,543,902 9.600% |
1,891,745 (+51.80%) |
Filing History |
| 2024-01-23 10:55 am Sale |
2023-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
STATE STREET CORP STT |
2,729,929 4.730% |
-1,062,997 (-28.03%) |
Filing History |
| 2023-12-18 4:15 pm Purchase |
2023-12-07 | 13G | Protagonist Therapeutics, Inc. PTGX |
Point72 Asset Management, L.P. | 3,186,077 5.500% |
2,818,071 (+765.77%) |
Filing History |
| 2023-04-13 4:30 pm Purchase |
2023-04-03 | 13G | Protagonist Therapeutics, Inc. PTGX |
ADAGE CAPITAL PARTNERS GP LLC | 2,955,000 5.440% |
1,804,955 (+156.95%) |
Filing History |
| 2023-03-20 5:04 pm Purchase |
2023-03-10 | 13G | Protagonist Therapeutics, Inc. PTGX |
BIOTECHNOLOGY VALUE FUND L P | 5,025,900 9.600% |
3,775,900 (+302.07%) |
Filing History |